Document is current
Any future updates will be listed below
-
Authors
Xiao, Yi
Wang, Yaxu
Gu, Haitao
Xu, Zhiquan
Tang, Yunhao
He, Hongmei
Peng, Linglong https://orcid.org/0000-0001-5774-3110
Xiang, Ling
-
Funding
Funding for this research was provided by:
Chongqing Science and Technology Foundation (cstc2021jcyj-msxmX0153)
Chongqing Science and Technology Commission (cstc2021jcyj-msxmX0112, CSTB2022NSCQ-MSX1005)
Kuanren Talents Project of the Second Affiliated Hospital of Chongqing Medical University in China (kryc-yq-2110)
- License Information
-
More Information
Article History
Received: 25 May 2023
Accepted: 11 July 2023
First Online: 19 July 2023
Declarations
:
: The study is in line with the Helsinki Declaration. The PLCO Cancer Screening Trial design was approved by the Institutional Review Board of the National Cancer Institute and each of the screening centers. Participants provided written informed consent prior to participation in this study.
: The authors declare no conflict of interest.
